MarketPeel
Insider Trading Intelligence
Pricing
…
DF

Daniel Faga

TRAX
PRESIDENT, CEO · FIRST TRACKS BIOTHERAPEUTICS, INC. · CIK 0001673528
FILING MIX · LIFETIME55%/45%
BUYS
40
SELLS
33
TOTAL VALUE
$14.14M
COMPANIES
2
ACTIVE SINCE
Nov 2021
HOLDINGS NOW
111,200
AVG SELL PX
$24.41
TRADE KIND
SHOWING 73 / 73
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons · 38 pending
Forward-return performance of every backtestable P/S trade by Daniel Faga, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+6.25%+2.43%+2.30%+0.13%-2.94%—
14d16+12.50%+15.01%+4.41%+10.60%+14.97%—
30d16+12.50%+47.62%+7.88%+39.74%+61.23%—
60d16+0.00%+43.17%+1.02%+20.70%+20.98%—
90d16+6.25%+41.95%+10.32%+31.62%+37.19%—
180d16(12 pending)+0.00%+70.25%+10.99%+59.25%+66.53%—
1y16(13 pending)+100.00%-22.69%+15.77%-38.47%-30.76%—
2y16(13 pending)+0.00%+77.70%+34.31%+43.39%+65.61%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TRAX · 100,200 shares · as of May 12, 2026
094,905189,810284,715379,620SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 40 buys / 33 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
100,200——100,200May 12, 2026May 14, 2026 ↗View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
271,100——271,100May 12, 2026May 14, 2026 ↗View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
69,355——69,355Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
133,400——133,400Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
194,900——194,900Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
305,500——305,500Apr 20, 2026Apr 22, 2026 ↗View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
379,620——379,620Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
379,620——379,620Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
9,200——9,200Apr 20, 2026Apr 22, 2026 ↗View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
133,400——133,400Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
133,400——133,400Apr 20, 2026Apr 22, 2026 ↗View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
305,500——305,500Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
9,200——9,200Apr 20, 2026Apr 22, 2026 ↗View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,200——9,200Apr 20, 2026Apr 22, 2026 ↗View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,000——11,000Apr 20, 2026Apr 22, 2026 ↗View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
98,600——98,600Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
379,620——379,620Apr 20, 2026Apr 22, 2026 ↗View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
194,900——194,900Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
11,000——11,000Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
2,321——2,321Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
194,900——194,900Apr 20, 2026Apr 22, 2026 ↗View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,321——2,321Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
2,321——2,321Apr 20, 2026Apr 22, 2026 ↗View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,850——17,850Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
305,500——305,500Apr 20, 2026Apr 22, 2026 ↗View →
TRAX
FIRST TRACKS BIOTHERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,512——80,512Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
11,000——16,510Apr 20, 2026Apr 22, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
11,000——11,000Apr 20, 2026Apr 23, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
2,592$63.35$164.2K502,258Mar 27, 2026Mar 27, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
100$65.99$6.6K495,965Mar 27, 2026Mar 27, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
2,570$57.91$148.8K510,564Mar 27, 2026Mar 27, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
490$59.62$29.2K506,412Mar 27, 2026Mar 27, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
510$56.61$28.9K513,134Mar 27, 2026Mar 27, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
1,012$62.15$62.9K504,850Mar 27, 2026Mar 27, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
3,038$65.20$198.1K496,065Mar 27, 2026Mar 27, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
3,662$58.62$214.7K506,902Mar 27, 2026Mar 27, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
550$60.63$33.3K505,862Mar 27, 2026Mar 27, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
3,155$64.19$202.5K499,103Mar 27, 2026Mar 27, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
34,300——513,644Mar 25, 2026Mar 27, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
14,281$44.71$638.5K479,344Jan 8, 2026Jan 9, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
9,202$45.11$415.1K466,787Jan 7, 2026Jan 8, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
26,838——80,512Jan 7, 2026Jan 9, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
President, CEO
26,838——493,625Jan 7, 2026Jan 9, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
President, CEO
17,850——475,989Jan 6, 2026Jan 8, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
133,400——133,400Jan 6, 2026Jan 8, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
98,600——98,600Jan 6, 2026Jan 8, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
17,850——17,850Jan 6, 2026Jan 8, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
15,309$43.26$662.3K458,139Jan 5, 2026Jan 6, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
34,677——69,355Jan 3, 2026Jan 6, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
President, CEO
34,677——473,448Jan 3, 2026Jan 6, 2026 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
107,350——107,350Jan 7, 2025Jan 7, 2025 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
305,500——305,500Jan 7, 2025Jan 7, 2025 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
President, CEO
17,850——442,853Jan 6, 2025Jan 7, 2025 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
17,850——35,700Jan 6, 2025Jan 7, 2025 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
6,387$15.30$97.7K436,466Jan 6, 2025Jan 7, 2025 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
34,678——104,032Jan 3, 2025Jan 7, 2025 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
President, CEO
34,678——438,036Jan 3, 2025Jan 7, 2025 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
President, CEO
13,033$14.60$190.3K425,003Jan 3, 2025Jan 7, 2025 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
160,000——160,000Jul 22, 2024Jul 24, 2024 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
CEO
347,441$21.60$7.50M401,646Mar 26, 2024Mar 26, 2024 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
CEO
3,000$21.42$64.3K749,087Mar 25, 2024Mar 26, 2024 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
CEO
145,940$22.78$3.33M752,087Mar 22, 2024Mar 26, 2024 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
CEO
6,866$21.81$149.7K898,027Jan 8, 2024Jan 9, 2024 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASE
CEO
17,850——904,893Jan 6, 2024Jan 9, 2024 ↗View →
ANAB
ANAPTYSBIO, INC
SALE
CEO
17,850——53,550Jan 6, 2024Jan 9, 2024 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
379,620——379,620Jan 3, 2024Jan 5, 2024 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
138,710——138,710Jan 3, 2024Jan 5, 2024 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
194,900——194,900Jan 6, 2023Jan 10, 2022 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
71,400——71,400Jan 6, 2023Jan 10, 2022 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
887,043——887,043Mar 21, 2022Mar 23, 2022 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
9,200——9,200Feb 10, 2022Feb 14, 2022 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
2,321——2,321Nov 26, 2021Nov 30, 2021 ↗View →
ANAB
ANAPTYSBIO, INC
PURCHASEGRANT
Stock grant
11,000——11,000Nov 26, 2021Nov 30, 2021 ↗View →
Other insiders · TRAX
Loading peer insiders…
About this filer
CIK 0001673528
ROLE
President, CEO
PRIMARY
TRAX
COMPANIES
2
ACTIVE SINCE
Nov 2021
MARKETPEEL · /INSIDER/0001673528DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback